FR2230366B1 - - Google Patents

Info

Publication number
FR2230366B1
FR2230366B1 FR7417821A FR7417821A FR2230366B1 FR 2230366 B1 FR2230366 B1 FR 2230366B1 FR 7417821 A FR7417821 A FR 7417821A FR 7417821 A FR7417821 A FR 7417821A FR 2230366 B1 FR2230366 B1 FR 2230366B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7417821A
Other versions
FR2230366A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH725973A external-priority patent/CH581137A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2230366A1 publication Critical patent/FR2230366A1/fr
Application granted granted Critical
Publication of FR2230366B1 publication Critical patent/FR2230366B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FR7417821A 1973-05-22 1974-05-22 Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity Granted FR2230366A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH725973A CH581137A5 (en) 1973-05-22 1973-05-22 Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity
CH725773 1973-05-22
CH725873 1973-05-22
CH1694073 1973-12-04
CH442574 1974-03-29

Publications (2)

Publication Number Publication Date
FR2230366A1 FR2230366A1 (en) 1974-12-20
FR2230366B1 true FR2230366B1 (fr) 1977-11-10

Family

ID=27509197

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417821A Granted FR2230366A1 (en) 1973-05-22 1974-05-22 Pyrazolo(1,5-a)-s-triazines - and their salts, with bronchospasmolytic activity

Country Status (8)

Country Link
JP (1) JPS5019769A (fr)
AU (1) AU6925974A (fr)
DD (1) DD113907A5 (fr)
DE (1) DE2424334A1 (fr)
FI (1) FI146174A (fr)
FR (1) FR2230366A1 (fr)
IL (1) IL44873A0 (fr)
NL (1) NL7406641A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH635587A5 (fr) * 1978-01-09 1983-04-15 Aron Sa Derives amines de pyrazolo (1,5-a) s.triazine, therapeutiquement actifs et leurs procedes de preparation.
DE3942357A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh 3-aminopyrazolo-heterocyclen, deren verwendung zur bestimmung von wasserstoffperoxid, wasserstoffperoxid-bildenden systemen, peroxidase, peroxidatisch wirksamen substanzen oder von elektronenreichen aromatischen verbindungen, entsprechende bestimmungsverfahren und hierfuer geeignete mittel
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
FR2850653A1 (fr) * 2003-02-04 2004-08-06 Univ Pasteur Derives de pyrazolotriazine, procede de preparation et utilisations
EP1633756B1 (fr) 2003-04-09 2008-12-24 Biogen Idec MA Inc. Antagonistes de recepteur d'adenosine a2a
WO2004092170A2 (fr) * 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolotriazines et pyrazolotriazines et leurs procedes de fabrication et d'utilisation
US7674791B2 (en) 2003-04-09 2010-03-09 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
TW200536536A (en) 2004-02-25 2005-11-16 Schering Corp Pyrazolotriazines as kinase inhibitors
AU2009233963B2 (en) 2008-04-07 2011-10-06 Irm Llc Compounds and compositions as kinase inhibitors
CA2787714C (fr) 2010-01-22 2019-04-09 Joaquin Pastor Fernandez Inhibiteurs de la pi3 kinase
WO2011141713A1 (fr) 2010-05-13 2011-11-17 Centro Nacional De Investigaciones Oncologicas (Cnio) Nouveaux composés bicycliques en tant qu'inhibiteurs de pi3-k et de mtor
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物
CN118284610A (zh) * 2021-11-23 2024-07-02 原真股份有限公司 用作cdk9抑制剂的吡唑并三嗪衍生物

Also Published As

Publication number Publication date
IL44873A0 (en) 1974-07-31
FI146174A (fr) 1974-11-23
AU6925974A (en) 1975-11-27
JPS5019769A (fr) 1975-03-01
DE2424334A1 (de) 1974-12-19
DD113907A5 (fr) 1975-07-05
NL7406641A (fr) 1974-11-26
FR2230366A1 (en) 1974-12-20

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465434B2 (fr)
FR2230366B1 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU472848B2 (fr)
AU476696B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AR201432A1 (fr)
AU461342B2 (fr)
AU477824B2 (fr)
AU447540B2 (fr)
AR210729A1 (fr)
AU476873B1 (fr)
AR193950A1 (fr)
AR197627A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse